The Heterocellular Emergence of Colorectal Cancer

Trends in Cancer

Volumn 3, Issue 2, 2017, Pages 79-88

  Tape, Christopher J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL COMMUNICATION; CELLS BY BODY ANATOMY; COLORECTAL CANCER; HUMAN; INTRACELLULAR SIGNALING; LAMINA PROPRIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOGENICITY; TUMOR MICROENVIRONMENT; CELL CLONE; CELL LINEAGE; COLORECTAL TUMOR; GENETIC HETEROGENEITY; GENETICS; PATHOLOGY; SIGNAL TRANSDUCTION;

CELL COMMUNICATION; CELL LINEAGE; CLONE CELLS; COLORECTAL NEOPLASMS; GENETIC HETEROGENEITY; HUMANS; SIGNAL TRANSDUCTION;

EID: 85009766732     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2016.12.004     Document Type: Review

References (83)

1. 1 Bianconi, E., et al. An estimation of the number of cells in the human body. Ann. Hum. Biol. 40 (2013), 463–471.
2. 2 Tape, C.J., Systems biology analysis of heterocellular signaling. Trends Biotechnol. 34 (2016), 627–637.
3. 3 Peterson, L.W., Artis, D., Intestinal epithelial cells: regulators of barrier function and immune homeostasis. Nat. Rev. Immunol. 14 (2014), 141–153.
4. 4 Powell, D.W., et al. Mesenchymal cells of the intestinal lamina propria. Annu. Rev. Physiol. 73 (2011), 213–237.
5. 5 Mowat, A.M., Agace, W.W., Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14 (2014), 667–685.
6. 6 Tauriello, D.V.F., Batlle, E., Targeting the microenvironment in advanced colorectal cancer. Trends Cancer 2 (2016), 495–504.
7. 7 Miller-Jensen, K., et al. Common effector processing mediates cell-specific responses to stimuli. Nature 448 (2007), 604–608.
8. 8 Iwamoto, N., et al. Context-specific flow through the MEK/ERK module produces cell- and ligand-specific patterns of ERK single and double phosphorylation. Sci. Signal., 9, 2016, ra13.
9. 9 Tape, C.J., et al. Oncogenic KRAS regulates tumor cell signaling via stromal reciprocation. Cell 165 (2016), 910–920.
10. 10 Goldstein, J., Emergence as a construct: history and issues. Emergence 1 (1999), 49–72.
11. 11 Quante, M., et al. The gastrointestinal tumor microenvironment. Gastroenterology 145 (2013), 63–78.
12. 12 Quail, D.F., Joyce, J.A., Microenvironmental regulation of tumor progression and metastasis. Nat. Med. 19 (2013), 1423–1437.
13. 13 Isella, C., et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 47 (2015), 312–319.
14. 14 Calon, A., et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47 (2015), 320–329.
15. 15 Trinh, A., et al. Practical and robust identification of molecular subtypes in colorectal cancer by immunohistochemistry. Clin. Cancer Res., 2016, 10.1158/1078-0432.CCR-16-0680 Published online December 9, 2016.
16. 16 Fessler, E., Medema, J.P., Colorectal cancer subtypes: developmental irigin and microenvironmental regulation. Trends Cancer 2 (2016), 505–518.
17. 17 Cancer Genome Atlas Network, Comprehensive molecular characterization of human colon and rectal cancer. Nature 487 (2012), 330–337.
18. 18 Sottoriva, A., et al. A big bang model of human colorectal tumor growth. Nat. Genet. 47 (2015), 209–216.
19. 19 Fodde, R., et al. signal transduction and genetic instability in colorectal cancer. Nat. Rev. Cancer 1 (2001), 55–67.
20. 20 Downward, J., Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3 (2003), 11–22.
21. 21 Crosnier, C., et al. Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat. Rev. Genet. 7 (2006), 349–359.
22. 22 van den Brink, G.R., Hedgehog signaling in development and homeostasis of the gastrointestinal tract. Physiol. Rev. 87 (2007), 1343–1375.
23. 23 Gregorieff, A., et al. Expression pattern of Wnt signaling components in the adult intestine. Gastroenterology 129 (2005), 626–638.
24. 24 Cui, G., et al. Progressive cellular response in the lamina propria of the colorectal adenoma–carcinoma sequence. Histopathology 54 (2009), 550–560.
25. 25 Hawinkels, L.J., et al. Interaction with colon cancer cells hyperactivates TGF-beta signaling in cancer-associated fibroblasts. Oncogene 33 (2014), 97–107.
26. 26 Tsujino, T., et al. Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin. Cancer Res. 13 (2007), 2082–2090.
27. 27 Ueno, H., et al. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53 (2004), 581–586.
28. 28 Sis, B., et al. Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. J. Clin. Pathol. 58 (2005), 32–38.
29. 29 Crispino, P., et al. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication. Cancer Invest. 26 (2008), 419–425.
30. 30 Conti, J.A., et al. The desmoplastic reaction surrounding hepatic colorectal adenocarcinoma metastases aids tumor growth and survival via alphav integrin ligation. Clin. Cancer Res. 14 (2008), 6405–6413.
31. 31 Jiang, L., et al. EpCAM-dependent extracellular vesicles from intestinal epithelial cells maintain intestinal tract immune balance. Nat. Commun., 7, 2016, 13045.
32. 32 Maywald, R.L., et al. IL-33 activates tumor stroma to promote intestinal polyposis. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), E2487–E2496.
33. 33 Shao, J., Roles of myofibroblasts in prostaglandin E2-stimulated intestinal epithelial proliferation and angiogenesis. Cancer Res. 66 (2006), 846–855.
34. 34 Vermeulen, L., De Sousa, E.M.F., van der Heijden, M., Cameron, K., de Jong, J.H., Borovski, T., Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat. Cell Boil. 12 (2010), 468–476.
35. 35 Henriksson, M.L., et al. Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1/FGFR3 signaling and increased invasion. Am. J. Pathol. 178 (2011), 1387–1394.
36. 36 Nakagawa, H., et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23 (2004), 7366–7377.
37. 37 Zhang, Y., et al. Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration. Eur. J. Cancer. 49 (2013), 3320–3334.
38. 38 Popivanova, B.K., et al. Blockade of a chemokine, CCL2, reduces chronic colitis-associated carcinogenesis in mice. Cancer Res. 69 (2009), 7884–7892.
39. 39 Grivennikov, S., et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15 (2009), 103–113.
40. 40 Schneider, M.R., et al. Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett. 151 (2000), 31–38.
41. 41 Erreni, M., et al. Tumor-associated macrophages (TAM) and inflammation in colorectal cancer. Cancer Microenviron. 4 (2011), 141–154.
42. 42 Chen, W., et al. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway. Oncotarget, 2016, 10.18632/oncotarget.12807 Published online October 21, 2016.
43. 43 Afik, R., et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix. J. Exp. Med. 213 (2016), 2315–2331.
44. 44 Ling, K.L., et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients. Cancer Immun., 7, 2007, 7.
45. 45 Tran, E., et al. Immunogenicity of somatic mutations in human gastrointestinal cancers. Science 350 (2015), 1387–1390.
46. 46 Tran, E., et al. T-cell transfer therapy targeting mutant KRAS in cancer. N. Engl. J. Med. 375 (2016), 2255–2262.
47. + T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58 (1998), 3491–3494.
48. 48 Galon, J., et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science, 313, 2006 1960–194.
49. 49 Ogino, S., et al. Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype. Clin Cancer Res. 15 (2009), 6412–6420.
50. 50 Mlecnik, B., et al. Integrative analyses of colorectal cancer show immunoscore is a stronger predictor of patient survival than microsatellite instability. Immunity 44 (2016), 698–711.
51. 51 Ong, S.M., et al. Macrophages in human colorectal cancer are pro-inflammatory and prime T cells towards an anti-tumour type-1 inflammatory response. Eur. J. Immunol. 42 (2012), 89–100.
52. 52 Mlecnik, B., et al. The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis. Sci. Transl. Med., 8, 2016, 327ra26.
53. 53 Berntsson, J., et al. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Int. J. Cancer 139 (2016), 1129–1139.
54. 54 Pang, G., et al. GM-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha. Clin. Exp. Immunol. 96 (1994), 437–443.
55. 55 Saada, J.I., et al. Subepithelial myofibroblasts are novel nonprofessional APCs in the human colonic mucosa. J. Immunol. 177 (2006), 5968–5979.
56. 56 Fletcher, A.L., et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207 (2010), 689–697.
57. + T-cell activity. Gastroenterology 135 (2008), 1228–1237.
58. + regulatory T cells. Gastroenterology 140 (2011), 2019–2030.
59. 59 Calon, A., et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell 22 (2012), 571–584.
60. 60 Putoczki, T.L., et al. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24 (2013), 257–271.
61. 61 Jones, S., et al. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J. Immunol. 179 (2007), 2824–2831.
62. 62 Santos, A.M., et al. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 119 (2009), 3613–3625.
63. 63 Akimoto, M., et al. Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment. Nat Commun., 7, 2016, 13589.
64. 64 Markman, J.L., Shiao, S.L., Impact of the immune system and immunotherapy in colorectal cancer. J. Gastrointest. Oncol. 6 (2015), 208–223.
65. 65 Halama, N., et al. Tumoral immune cell exploitation in colorectal cancer metastases can be targeted effectively by anti-CCR5 therapy in cancer patients. Cancer Cell. 29 (2016), 587–601.
66. 66 Drake, C.G., et al. Breathing new life into immunotherapy: review of melanoma, lung and kidney cancer. Nat. Rev. Clin. Oncol. 11 (2014), 24–37.
67. 67 Llosa, N.J., et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 5 (2015), 43–51.
68. 68 Le, D.T., et al. PD-1 blockade in tumors with mismatch-repair deficiency. N. Engl. J. Med. 372 (2015), 2509–2520.
69. 69 De Henau, O., et al. Overcoming resistance to checkpoint blockade therapy by targeting PI3Kgamma in myeloid cells. Nature 539 (2016), 443–447.
70. 70 Garrido-Laguna, I., Hidalgo, M., Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat. Rev. Clin. Oncol. 12 (2015), 319–334.
71. 71 de la Roche, M., et al. Hedgehog signaling controls T cell killing at the immunological synapse. Science 342 (2013), 1247–1250.
72. 72 Gauthier, N.P., et al. Cell-selective labeling using amino acid precursors for proteomic studies of multicellular environments. Nat. Methods 10 (2013), 768–773.
73. 73 Tape, C.J., et al. Cell-specific labeling enzymes for analysis of cell–cell communication in continuous co-culture. Mol. Cell Proteomic. 13 (2014), 1866–1876.
74. 74 Spitzer, M.H., Nolan, G.P., Mass cytometry: single cells, many features. Cell 165 (2016), 780–791.
75. 75 Simmons, A.J., et al. Cytometry-based single-cell analysis of intact epithelial signaling reveals MAPK activation divergent from TNF-alpha-induced apoptosis in vivo. Mol. Syst. Biol., 11, 2015, 835.
76. 76 Amir el, A.D., et al. viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia. Nat. Biotechnol. 31 (2013), 545–552.
77. 77 Spitzer, M.H., et al. An interactive reference framework for modeling a dynamic immune system. Science, 349, 2015, 1259425.
78. 78 Krishnaswamy, S., et al. Conditional density-based analysis of T cell signaling in single-cell data. Science, 346, 2014, 1250689.
79. 79 Bussard, K.M., et al. Tumor-associated stromal cells as key contributors to the tumor microenvironment. Breast Cancer Res., 18, 2016, 84.
80. 80 Ying, H., et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 30 (2016), 355–385.
81. 81 Taddei, M.L., et al. Microenvironment and tumor cell plasticity: an easy way out. Cancer Lett. 341 (2013), 80–96.
82. 82 Hansen, J.M., et al. Targeting the tumour microenvironment in ovarian cancer. Eur. J. Cancer 56 (2016), 131–143.
83. 83 Uhlen, M., et al. Tissue-based map of the human proteome. Science, 347, 2015, 1260419.